Delivery Order SPE2DB24D3013-SPE2DB26FFGFQ
Award Date 11/7/25
Potential Completion Date 11/10/25
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,980.90 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed price delivery order, issued without set-aside designation, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication primarily used to treat autoimmune and inflammatory conditions including...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,831.00 for TALTZ 80 mg/ml autoinjector on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order is not set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication commonly prescribed for autoimmune conditions including psoriasis, psoriatic arthritis,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Auto-Injector with a ceiling value of $6,500.68 under firm fixed pricing. This non-competitive delivery order is scheduled for completion by August 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a prescription biologic medication used to treat inflammatory conditions, and the auto-injector formulation provides...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,715.74 for TALTZ 80 MG/ML AutoInjector on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication commonly prescribed for...
- The Defense Logistics Agency awarded a $7,021.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML autoinjector on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,463.75 for TALTZ 80 mg/ml autoinjector on November 5, 2025, with an ultimate completion date of November 6, 2025. This is a firm fixed price, non-set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The delivery order will be fulfilled from...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,670.76 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL AutoInjector (2-pack) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used in the treatment of autoimmune...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,399.82 for TALTZ 80 MG/ML AutoInjector on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $15,104.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on May 16, 2025, with an ultimate completion date of May 19, 2025. This contract is a non-set-aside award and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic...